Matthew A. Whitman
Cornell University(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Ubiquitin and proteasome pathways, Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities, Cancer Cells and Metastasis, Microtubule and mitosis dynamics
Most-Cited Works
- → Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors(2016)328 cited
- → Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes(2018)99 cited
- → Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis(2018)72 cited
- → REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks(2020)53 cited
- → Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer(2023)41 cited
- → Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS)(2019)34 cited
- → VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells(2019)29 cited
- → Synergistic interactions with PI3K inhibition that induce apoptosis(2017)28 cited
- → Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling(2022)21 cited
- → Parallel In Vivo Assessment of Drug Phenotypes at Various Time Points during Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities(2016)21 cited